amphetamine has been researched along with remoxipride in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Ahlenius, S; Ericson, E | 1 |
| Angeby-Möller, K; Hall, H; Ogren, SO; Widman, M | 1 |
| Copinga, S; Grol, CJ; Homan, EJ; Jackson, DM; Unelius, L; Wikström, HV | 1 |
| Cools, AR; Ellenbroek, BA; van der Elst, MC; Wunderink, YS | 1 |
6 other study(ies) available for amphetamine and remoxipride
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Phencyclidine-induced disruption of an aversely motivated two-choice successive discrimination in the rat.
Topics: Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Benzamides; Discrimination Learning; Discrimination, Psychological; Drug Interactions; Haloperidol; Male; Phencyclidine; Rats; Rats, Inbred Strains; Remoxipride | 1990 |
Effects of remoxipride's metabolites on dopamine D2 receptors and receptor functions in the rat.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Hypothermia; In Vitro Techniques; Male; Motor Activity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride | 1993 |
Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzamides; Catalepsy; Cells, Cultured; Cyclic AMP; Dopamine Agents; Humans; Inhibitory Concentration 50; Isomerism; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Remoxipride; Serotonin Agents; Structure-Activity Relationship; Tetrahydronaphthalenes; Vasoactive Intestinal Peptide | 1999 |
Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Apomorphine; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Inhibition, Psychological; Injections, Intraperitoneal; Male; Neurons; Rats; Rats, Inbred Strains; Reflex, Startle; Remoxipride; Reserpine; Schizophrenic Psychology | 2007 |